• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疲劳影响量表在匈牙利多发性硬化症患者中的验证。

Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis.

机构信息

Department of Neurology, Albert Szent-Györgyi Clinical Centre, University of Szeged, 6 Semmelweis u., 6725, Szeged, Hungary.

出版信息

Qual Life Res. 2011 Mar;20(2):301-6. doi: 10.1007/s11136-010-9749-7. Epub 2010 Sep 24.

DOI:10.1007/s11136-010-9749-7
PMID:20865452
Abstract

PURPOSE

Fatigue is one of the most frequent complaints of patients with multiple sclerosis (MS). The Fatigue Impact Scale (FIS), one of the 30 available fatigue questionnaires, is commonly applied because it evaluates multidimensional aspects of fatigue. The main purposes of this study were to test the validity, test-retest reliability, and internal consistency of the Hungarian version of the FIS.

METHODS

One hundred and eleven MS patients and 85 healthy control (HC) subjects completed the FIS and the Beck Depression Inventory, a large majority of them on two occasions, 3 months apart.

RESULTS

The total FIS score and subscale scores differed statistically between the MS patients and the HC subjects in both FIS sessions. In the test-retest reliability assessment, statistically, the intraclass correlation coefficients were high in both the MS and HC groups. Cronbach's alpha values were also notably high.

CONCLUSIONS

The results of this study indicate that the FIS can be regarded as a valid and reliable scale with which to improve our understanding of the impact of fatigue on the health-related quality of life in MS patients without severe disability.

摘要

目的

疲劳是多发性硬化症(MS)患者最常见的抱怨之一。疲劳影响量表(FIS)是 30 种可用的疲劳问卷之一,因其评估疲劳的多维方面而被广泛应用。本研究的主要目的是检验 FIS 的匈牙利文版本的效度、重测信度和内部一致性。

方法

111 名 MS 患者和 85 名健康对照组(HC)受试者完成了 FIS 和贝克抑郁量表,他们中的绝大多数在 3 个月的间隔时间内完成了两次测试。

结果

在两次 FIS 测试中,MS 患者和 HC 受试者的 FIS 总分和子量表评分在统计学上存在显著差异。在重测信度评估中,MS 和 HC 组的组内相关系数均较高。克朗巴赫的α值也非常高。

结论

本研究的结果表明,FIS 可以被视为一种有效的、可靠的量表,它可以帮助我们更好地理解疲劳对无严重残疾的 MS 患者健康相关生活质量的影响。

相似文献

1
Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis.疲劳影响量表在匈牙利多发性硬化症患者中的验证。
Qual Life Res. 2011 Mar;20(2):301-6. doi: 10.1007/s11136-010-9749-7. Epub 2010 Sep 24.
2
Validation of the Fatigue Impact Scale in Multiple Sclerosis Patients in Serbia.塞尔维亚多发性硬化症患者疲劳影响量表的验证
Brain Sci. 2024 Aug 17;14(8):825. doi: 10.3390/brainsci14080825.
3
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.《简短国际多发性硬化症认知评估量表(BICAMS)》在匈牙利的验证以及认知障碍与疲劳和生活质量的相关性。
Mult Scler Relat Disord. 2015 Nov;4(6):499-504. doi: 10.1016/j.msard.2015.07.006. Epub 2015 Jul 8.
4
Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients.验证疲劳影响量表和疲劳严重程度量表的俄罗斯版本在多发性硬化症患者中的应用。
Acta Neurol Scand. 2018 Nov;138(5):408-416. doi: 10.1111/ane.12993. Epub 2018 Jul 9.
5
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.伊朗多发性硬化症患者使用改良疲劳影响量表(MFIS)问卷的波斯语版本的有效性和可靠性。
Disabil Rehabil. 2013 Aug;35(18):1509-12. doi: 10.3109/09638288.2012.742575. Epub 2012 Dec 14.
6
Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients.多发性硬化症患者中疲劳影响量表土耳其语版本的心理测量学研究。
J Neurol Sci. 2007 Apr 15;255(1-2):64-8. doi: 10.1016/j.jns.2007.01.073. Epub 2007 Mar 6.
7
Validity and reliability of the multidimensional assessment of fatigue scale in Iranian patients with relapsing-remitting subtype of multiple sclerosis.多维疲劳评估量表在伊朗复发缓解型多发性硬化症患者中的有效性和可靠性
Disabil Rehabil. 2018 Mar;40(6):673-677. doi: 10.1080/09638288.2016.1271024. Epub 2017 Mar 21.
8
The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS).多维疲劳影响量表(U-FIS)的编制与验证。
Mult Scler. 2009 Oct;15(10):1228-38. doi: 10.1177/1352458509106714. Epub 2009 Jun 25.
9
Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis.多发性硬化症患者疲劳影响量表的重测信度和收敛效度。
Am J Occup Ther. 2003 Jul-Aug;57(4):389-95. doi: 10.5014/ajot.57.4.389.
10
Validity and reliability of the fatigue impact scale in stroke.脑卒中疲劳影响量表的效度和信度。
Top Stroke Rehabil. 2022 Oct;29(7):526-537. doi: 10.1080/10749357.2021.1978629. Epub 2021 Sep 20.

引用本文的文献

1
NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.那他珠单抗治疗的多发性硬化症患者的无疾病活动状态、心理症状和生活质量稳定:一项长达6年的随访研究。
Heliyon. 2024 Oct 18;10(20):e39536. doi: 10.1016/j.heliyon.2024.e39536. eCollection 2024 Oct 30.
2
Validation of the Fatigue Impact Scale in Multiple Sclerosis Patients in Serbia.塞尔维亚多发性硬化症患者疲劳影响量表的验证
Brain Sci. 2024 Aug 17;14(8):825. doi: 10.3390/brainsci14080825.
3
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis.

本文引用的文献

1
Fatigue: an overview.疲劳:概述
Am Fam Physician. 2008 Nov 15;78(10):1173-9.
2
Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.多发性硬化症的疲劳特征:北美多发性硬化症研究委员会(NARCOMS)调查
Health Qual Life Outcomes. 2008 Nov 14;6:100. doi: 10.1186/1477-7525-6-100.
3
Validity of a French version of the fatigue impact scale in multiple sclerosis.法语版疲劳影响量表在多发性硬化症中的效度
疲劳和抑郁会影响多发性硬化症患者焦虑症的患病率。
Neurol Sci. 2025 Jan;46(1):325-334. doi: 10.1007/s10072-024-07737-9. Epub 2024 Aug 23.
4
The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients.匈牙利 BICAMS 验证队列的 7 年随访结果表明,多发性硬化症患者的认知表现可能会改善。
Neurol Sci. 2024 Jul;45(7):3369-3378. doi: 10.1007/s10072-024-07347-5. Epub 2024 Jan 27.
5
Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study.口服特立氟胺治疗两年的匈牙利复发缓解型多发性硬化症患者生活质量良好的真实世界证据:Teri-REAL研究结果
Pharmaceuticals (Basel). 2022 May 13;15(5):598. doi: 10.3390/ph15050598.
6
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation.醋酸格拉替雷免疫调节:神经保护和认知功能保留的证据。
Cells. 2022 May 7;11(9):1578. doi: 10.3390/cells11091578.
7
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.多发性硬化中的神经退行性变:沉默进展的症状、生物标志物和神经保护治疗——犬尿氨酸是重要的参与者。
Molecules. 2021 Jun 5;26(11):3423. doi: 10.3390/molecules26113423.
8
Comparison of the Psychometric Properties of Three Fatigue Scales in Persian-Speaking Patients with Multiple Sclerosis.三种疲劳量表在波斯语多发性硬化症患者中的心理测量特性比较
Int J MS Care. 2021 Jan-Feb;23(1):8-15. doi: 10.7224/1537-2073.2019-051. Epub 2020 Feb 14.
9
Contributing factors to health-related quality of life in multiple sclerosis.多发性硬化症患者健康相关生活质量的影响因素。
Brain Behav. 2019 Dec;9(12):e01466. doi: 10.1002/brb3.1466. Epub 2019 Nov 11.
10
Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties.多发性硬化症、帕金森病和中风患者的自报告疲劳问卷:测量特性的系统评价。
Qual Life Res. 2012 Aug;21(6):925-44. doi: 10.1007/s11136-011-0009-2. Epub 2011 Oct 20.
Mult Scler. 2007 Sep;13(8):1026-32. doi: 10.1177/1352458507077942.
4
Origin of fatigue in multiple sclerosis: review of the literature.多发性硬化症中疲劳的起源:文献综述
Neurorehabil Neural Repair. 2008 Jan-Feb;22(1):91-100. doi: 10.1177/1545968306298934. Epub 2007 Apr 4.
5
Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients.多发性硬化症患者中疲劳影响量表土耳其语版本的心理测量学研究。
J Neurol Sci. 2007 Apr 15;255(1-2):64-8. doi: 10.1016/j.jns.2007.01.073. Epub 2007 Mar 6.
6
Reliability and validity of the Swedish version of the Fatigue Impact Scale (FIS).瑞典版疲劳影响量表(FIS)的信度和效度。
Scand J Occup Ther. 2005 Dec;12(4):170-80. doi: 10.1080/11038120510031806.
7
Fatigue in multiple sclerosis is related to disability, depression and quality of life.多发性硬化症中的疲劳与残疾、抑郁及生活质量相关。
J Neurol Sci. 2006 Apr 15;243(1-2):39-45. doi: 10.1016/j.jns.2005.11.025. Epub 2006 Jan 24.
8
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?多发性硬化症中的疲劳:细胞因子介导的疾病行为的一个例子?
J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):34-9. doi: 10.1136/jnnp.2005.065805.
9
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".多发性硬化症的诊断标准:对“麦克唐纳标准”的2005年修订版。
Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703.
10
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.多发性硬化症和疲劳患者体内细胞因子mRNA的表达
Mult Scler. 2004 Apr;10(2):165-9. doi: 10.1191/1352458504ms991oa.